drugset / Trial / NCT00386360

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

NCT00386360

Phase 3 Completed 161 enrolled Warner Chilcott
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary purpose of the protocol is to evaluate the sensitivity of 3D-pQCT (3D-Peripheral Quantitative Computed Tomography) technology to detect minute changes in bone microarchitecture.

Timeline

Start
2006-04
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Risedronate Small molecule 35 mg

Indications